Enzo Biochem, Inc. Share Price

Equities

ENZ

US2941001024

Biotechnology & Medical Research

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
1.05 USD -1.87% Intraday chart for Enzo Biochem, Inc. -3.67% -24.46%
Sales 2022 107M 8.93B Sales 2023 31.06M 2.59B Capitalization 73.6M 6.14B
Net income 2022 -18M -1.5B Net income 2023 20M 1.67B EV / Sales 2022 1.07 x
Net cash position 2022 1.02M 84.76M Net cash position 2023 75.38M 6.29B EV / Sales 2023 -0.06 x
P/E ratio 2022
-6.24 x
P/E ratio 2023
3.59 x
Employees 185
Yield 2022 *
-
Yield 2023
-
Free-Float 75.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.87%
1 week-3.67%
Current month-17.32%
1 month-17.32%
3 months-19.23%
6 months-23.91%
Current year-24.46%
More quotes
1 week
1.04
Extreme 1.04
1.11
1 month
1.04
Extreme 1.04
1.30
Current year
1.04
Extreme 1.04
1.50
1 year
1.04
Extreme 1.04
2.74
3 years
1.00
Extreme 1
4.15
5 years
1.00
Extreme 1
4.85
10 years
1.00
Extreme 1
12.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/11/01
Founder 81 01/76/01
Director of Finance/CFO 47 -
Members of the board TitleAgeSince
Chairman 64 26/23/26
Director/Board Member 58 17/20/17
Director/Board Member 50 03/22/03
More insiders
Date Price Change Volume
26/24/26 1.05 -1.87% 114,913
25/24/25 1.07 +0.94% 74,257
24/24/24 1.06 -2.75% 77,230
23/24/23 1.09 0.00% 76,123
22/24/22 1.09 0.00% 120,187

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.
More about the company